Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Chronic Hepatitis C”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Large-scale testing (Phase 3)WithdrawnNCT01641666
What this trial is testing

Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01399619
What this trial is testing

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 310
Testing effectiveness (Phase 2)Study completedNCT01782495
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 129
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)Study completedNCT00606086
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Who this might be right for
Genotype 1 Chronic Hepatitis C
GlobeImmune 140
Testing effectiveness (Phase 2)Study completedNCT02480387
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Who this might be right for
Treatment of Hepatitis C
Peter J. Ruane, M.D., Inc. 20
Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Large-scale testing (Phase 3)Study completedNCT02021656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 384
Post-approval studies (Phase 4)UnknownNCT02950870
What this trial is testing

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Who this might be right for
Chronic Hepatitis, C Virus
University of Modena and Reggio Emilia 75
Large-scale testing (Phase 3)Study completedNCT02597166
What this trial is testing

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, ChronicCirrhosis, Decompensated
University Health Network, Toronto 14
Post-approval studies (Phase 4)Ended earlyNCT00977054
What this trial is testing

Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load

Who this might be right for
Hepatitis C
National Taiwan University Hospital 59
Testing effectiveness (Phase 2)Study completedNCT03036839
What this trial is testing

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 95
Testing effectiveness (Phase 2)Study completedNCT02262728
What this trial is testing

An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 40
Testing effectiveness (Phase 2)Study completedNCT01331850
What this trial is testing

Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 381
Post-approval studies (Phase 4)Study completedNCT02220868
What this trial is testing

Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study

Who this might be right for
Hepatitis C InfectionHIV Infection
Saint Michael's Medical Center 10
Not applicableStudy completedNCT00724373
What this trial is testing

Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 442
Large-scale testing (Phase 3)Study completedNCT00381953
What this trial is testing

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Who this might be right for
Hepatitis C
Foundation for Liver Research 33
Post-approval studies (Phase 4)WithdrawnNCT02206932
What this trial is testing

The Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

Who this might be right for
Hepatitis C, ChronicHIV CDC Category A1
University of California, San Francisco
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation